Archive for the ‘IICB’ Category
To promote incubation centres, start-ups and entrepreneurship, the Indian Institute of Chemical Biology (IICB) and National Research Development Corporation (NRDC), both arms of the DSIR, have signed an MoU to facilitate industry-institute partnership.
IICB is a laboratory of Council of Scientific and Industrial Research (CSIR) which does research on diseases and biological problems plaguing the world. It is a part of the Department of Scientific and Industrial Research (DSIR) while the NRDC is a PSU under it….
Pointer to how kala azar trumps drugs – Parasite challenge tougher than thought, say city scientists
23 January 2013
NEW DELHI: Scientists in Calcutta say they have deciphered the molecular chicanery the parasite that causes kala azar unleashes to hijack the human body’s immune system and evade drugs used to treat this potentially fatal infection.
The researchers at the Indian Institute of Chemical Biology, Calcutta, and their collaborators say their findings suggest that the challenge posed by drug-resistant versions of the kala azar parasite may be even more formidable than hitherto believed……
09 November 2012
KOLKATA: Kala-azar, known to claim a few lives every year in North and East India, including West Bengal, may soon be a thing of the past, courtesy an effective vaccine developed by a city scientist.
Nahid Ali, a scientist at the Indian Institute of Chemical Biology (IICB) who worked on the vaccine for 10 years, has published a paper on her successful research in an international medical journal last month…..
20 November 2012
KOLKATA: Giving an insight into how and why hospital-borne infections spread, scientists at the Indian Institute of Chemical Biology here have said bacteria play hide and seek with the human body’s defence cells by surrounding themselves with sugar molecules to fool cells.
Researchers led by scientist Chitra Mandal have unravelled the sinister mechanism by which the bacteria that goes by the name of Pseudomonas aeruginosa, responsible for hospital-borne infections, invades the human body, eludes the neutrophils (immune cells responsible for defence) and establishes infection…..
16 September 2012
NEW DELHI: In a discovery that may save thousands of lives in rural India in future, scientists have found a cocktail of three herbal compounds, which can effectively neutralise the poison of Indian banded krait, when the concoction is applied together with commercial anti-snake venom serum.
The synthetic herbal compounds were found to be superior to the commercial anti-serum in cancelling the effect of venom of krait — one of the common poisonous snakes of India.
Scientists at the Indian Institute of Chemical Biology (IICB), Kolkata, and University of Calcutta, who identified, characterised and established the usefulness of these plant-based compounds, have suggested a combination therapy for snakebite victims…..
18 September 2012
KOLKATA: Chewing ‘paan’ or betel leaf could help fight a form of bone marrow cancer, a group of Indian researchers say.
A molecule derived from betel leaf may be beneficial to patients suffering from a cancer in which the bone marrow makes too many white blood cells and the body refuses to respond to common drugs, said a study by scientists in Kolkata and Mumbai.
An alcoholic extract of the betel leaves helps patients suffering from chronic myeloid leukaemia (CML) — the most common form of leukaemia in adults in India — holding out hope of improved treatment.
The research was carried out by the Indian Institute of Chemical Biology (IICB), the Institute of Haematology and Transfusion Medicine, Kolkata, and Piramal Life Sciences, Mumbai…..
10 September 2012
KOLKATA: Indian scientists have found a safe orally-administered drug against kala azar, a disease that puts at risk an estimated 165.4 million people in Bihar, Jharkhand, West Bengal and Uttar Pradesh.
Termed by WHO as a “neglected disease”, kala azhar or visceral leishmaniasis, the second-largest parasitic killer in the world after malaria, has proved resistant to most medicines.
………..Treatment of the disease was thus becoming more expensive, said Nahid Ali of the Infectious Diseases and Immunology Division at the Indian Institute of Chemical Biology (IICB) here. ………..